A couple who experienced the loss of their first child due to Meckel-Gruber syndrome opted for IVF with preimplantation genetic testing (PGT-M) to avoid repeating the tragedy. They created multiple embryos, with some labeled as unaffected or carriers of the condition. In 2019, they successfully gave birth to healthy twins using an embryo deemed unaffected. However, in 2023, an embryo previously labeled as a carrier resulted in a pregnancy diagnosed with Meckel-Gruber syndrome, leading to another difficult decision. The couple expressed shock and disbelief, as they had placed complete trust in the genetic testing process.
Bias read (Center): The article focuses on personal health experiences and medical procedures related to genetic testing and IVF. There is no political framing, controversy, or ideological emphasis present in the narrative. The content remains centered on individual medical decisions and outcomes.




